register

ESG

Hepatitis Australia announces new CEO

Health Industry Hub | March 6, 2020 |

Hepatitis Australia has appointed Carrie Fowlie as its incoming Chief Executive Officer.

Following the retirement of Helen Tyrrell at the beginning of February, Hepatitis Australia undertook a rigorous recruitment process to identify the person to take over the operational leadership of the organisation and work closely with the Board.

Hepatitis Australia President, A/Prof. Grant Phelps said, “the Board is delighted that Carrie has accepted the position of CEO.  Carrie brings deep experience and knowledge of the sector and is well known to and highly regarded by many who have worked with Hepatitis Australia.”

“Carrie is very well positioned to assist the Board and staff of Hepatitis Australia to continue to drive towards improving the lives of people with hepatitis B and hepatitis C and our vison of an end to viral hepatitis in Australia”

Carrie heads to Hepatitis Australia with almost two decades of peak body experience.

Carrie has extensive representational experience at the national and international level. Her work with elected officials and their offices, in parliaments, at the United Nations and with government officials has resulted in policies that are consistent with the evidence and the priorities of the constituencies she has represented.

Carrie Fowlie said, “the leadership of Hepatitis Australia with its members, affected communities, the sector and allies over the past decade has been transformative.”

“What an extraordinary opportunity, working together to achieve a shared goal of eliminating viral hepatitis by 2030.”

“I look forward to contributing to the health and wellbeing and strengthening the voices of around 400,000 Australians living with hepatitis B or hepatitis C and those who represent them.”

Acting CEO, Kevin Marriott says, “the staff team at Hepatitis Australia is excited to welcome Carrie and we look forward to her leadership and guidance into the future.

Carrie Fowlie will formally commence with Hepatitis Australia in mid-April, 2020.

Register FREE to receive the latest industry news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


News & Trends - MedTech & Diagnostics

Government commissions review as 70% of private hospitals face financial crisis

Government commissions review as 70% of private hospitals face financial crisis

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: Despite playing a crucial role in providing acute care and surgical services, a staggering 70% of […]

More


News & Trends - Pharmaceuticals

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Pharmacy Guild echoes ACCC red flags over Chemist Warehouse-Sigma deal

Health Industry Hub | June 14, 2024 |

Pharma News: The Pharmacy Guild of Australia has echoed the significant concerns of the Australian Competition and Consumer Commission (ACCC) […]

More


News & Trends - MedTech & Diagnostics

Competition watchdog raises concerns over cancer care provider's expansion plans

Competition watchdog raises concerns over cancer care provider’s expansion plans

Health Industry Hub | June 14, 2024 |

MedTech & Diagnostics News: A leading provider of cancer care services in Australia, faces scrutiny from the Australian Competition and […]

More


News & Trends - Biotechnology

Aussie biotech secures first local CAR T patent

Aussie biotech secures first local CAR T patent

Health Industry Hub | June 13, 2024 |

Biotech News: A Melbourne-based biotechnology company which specialises in developing immune cell therapies for cancer treatment, has been granted its […]

More


This content is copyright protected. Please subscribe to gain access.